Molluscum Contagiosum (MC) - Epidemiology Forecast - 2032

This ‘Molluscum Contagiosum (MC)- Epidemiology Forecast- 2032' report delivers an in-depth understanding of Molluscum Contagiosum (MC) historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Molluscum Contagiosum (MC) Disease Understanding

Molluscum Contagiosum, also called water warts, is a common superficial skin infection caused by the poxvirus. It is one of the 50 most frequent diseases worldwide which predominantly affects school-aged children, sexually active young adults, and immuno compromised individuals. It is characterized by painless white or skin-colored papular skin lesions that are generally 2-5 mm in size, though early lesions can be smaller. The skin lesions of MC are called mollusca, and a patient typically has 1-20 mollusca. In normal hosts, MC is benign natured limited to the skin, but lesions can take as long as 6-12 months to resolve. Immuno compromised patients can develop very large (>15 mm) and numerous lesions and bacterial super infections.

Molluscum Contagiosum (MC) Epidemiology

Molluscum Contagiosum epidemiology division provides insights into the historical and incident patient pool, along with the forecasted trend for all seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The report also provides the diagnosed patient pool, trends, and assumptions.

Key Findings

The total prevalent cases of Molluscum Contagiosum patients in the 7MM are increasing during the study period, i.e., 2019-2032.

The disease epidemiology covered in the report provides historical and forecasted Molluscum Contagiosum symptoms epidemiology segmented as the total prevalent cases and gender-specific cases of Molluscum Contagiosum. The report includes the prevalent cases of Molluscum Contagiosum in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2019 to 2032.

Country-wise Molluscum Contagiosum (MC) Epidemiology

The epidemiology segment also provides the Molluscum Contagiosum epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The prevalent cases of Molluscum Contagiosum associated in 7MM countries were around 12.6 million in 2021.

• As per the estimates, the United States has the largest prevalent population of Molluscum Contagiosum.

Among the EU5 countries, France had the highest prevalent cases of Molluscum Contagiosum with around 1.3 million cases whereas Spain had the lowest prevalent cases with around 680,000 cases in 2021.

Scope of the Report

• Molluscum Contagiosum report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
• Molluscum Contagiosum Epidemiology Report and Model provide an overview of its risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report provides insight into Molluscum Contagiosum historical and forecasted patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Molluscum Contagiosum.
• The report provides the segmentation of the Molluscum Contagiosum epidemiology by the prevalent cases of Molluscum Contagiosum in 7MM.
• The report provides the Molluscum Contagiosum epidemiology segmentation by gender-specific cases of Molluscum Contagiosum in 7MM.

Report Highlights

• 11-year Forecast of Molluscum Contagiosum epidemiology
• 7MM Coverage
• Prevalent Cases of Molluscum Contagiosum
• Gender-specific cases of Molluscum Contagiosum

KOL Views

The publisher interviews KOLs, and SMEs' opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatments by identifying the overall scenario of the indications.

Key Questions Answered

• What are the major factors that will drive the change in the patient population in Molluscum Contagiosum during the forecast period (2019-2032)?
• What are the key findings of the Molluscum Contagiosum epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2019-2032)?
• What would be the total number of Molluscum Contagiosum patients across the 7MM during the forecast period (2019-2032)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
• What are the disease risks, burdens, and unmet needs of the Molluscum Contagiosum market?
• What are the current treatment patterns for Molluscum Contagiosum?

Reasons to Buy

The Molluscum Contagiosum epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Molluscum Contagiosum market.
• Quantify patient populations in the global Molluscum Contagiosum market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and gender that present the best opportunities for Molluscum Contagiosum therapeutics in each market covered.
• Understand the magnitude of the Molluscum Contagiosum population by its prevalence.
• Understand the magnitude of the Molluscum Contagiosum population by its Gender-specific cases.
• Molluscum Contagiosum epidemiology report and model were written and developed by Master's and Ph.D. level epidemiologists.
• Molluscum Contagiosum epidemiology model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over an 11-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2019-2032